UBS Group
LABX

UBS Group’s Tradr 2X Long ALAB Daily ETF LABX Stock Holding History

UBS Group’s Portfolio LABX Stock Details LABX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-972
Closed -$7.4K – 11685
2025
Q4 		$7.4K Buy
+972
New +$8.71K ﹤0.01% 8448

Other funds holding LABX

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's LABX Position: Q1 2026 in Review

UBS Group sold out of Tradr 2X Long ALAB Daily ETF (LABX) in Q1 2026, closing a stake of 972 shares — an estimated $7.4K sold.

UBS Group first reported a position in LABX in Q4 2025 and held it in 1 quarter. The position peaked at $7.4K in Q4 2025. 6 funds tracked by Wall St. Rank hold LABX as of Q1 2026.

  • UBS Group reported no remaining Tradr 2X Long ALAB Daily ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 972 Tradr 2X Long ALAB Daily ETF shares in Q1 2026, an estimated $7.4K.
  • UBS Group first reported a position in Tradr 2X Long ALAB Daily ETF in Q4 2025 and held it in 1 quarter.
  • UBS Group's Tradr 2X Long ALAB Daily ETF position peaked at $7.4K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Tradr 2X Long ALAB Daily ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.